Sign In
Buy SNN
$31.56
-0.770 (-2.38%)
At Close: Jul 31, 2026
Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery
08:00am, Wednesday, 09'th Oct 2024
Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a co-ma
SNN Stock Rises on the Completion of First Case With CATALYSTEM System
12:51pm, Friday, 20'th Sep 2024
Smith & Nephew announces the completion of the first case using the CATALYSTEM Primary Hip System.
This stock is 'boring' but has 'fantastic' risk-reward: Scharf
12:40pm, Wednesday, 18'th Sep 2024
Eric Lynch from Scharf Investments explains why he likes the non-tech and utilities sectors.
First cases using Smith+Nephew's new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility
10:00am, Wednesday, 18'th Sep 2024
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces promising surgeon feedback from the first completed cases utilizing its new CATALYSTEM Primary Hip System. Desig
SNN Stock Declines Despite the Launch of Its Patient-Matched Guides
01:26pm, Friday, 13'th Sep 2024
Smith & Nephew announces the launch of its TOTAL ANKLE Patient-Matched Guides to plan and perform total ankle replacement procedures.
Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides
10:00am, Tuesday, 10'th Sep 2024
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its TOTAL ANKLE Patient-Matched Guides, giving surgeons a predictable and efficient option to help
Smith & Nephew Delivering On Its Turnaround Promise
08:30pm, Wednesday, 21'st Aug 2024
The Street has taken notice of Smith & Nephew's turnaround progress, with better than expected revenue and margin results driving share price outperformance. While the ortho business has continued to
Smith & Nephew (SNN) Partners InfuSystem for Renasys Edge
12:25pm, Monday, 12'th Aug 2024
Smith & Nephew (SNN) inks a three-year agreement with InfuSystem (INFU) to distribute its RENASYS EDGE negative pressure wound therapy system.
Smith & Nephew (SNN), HOPCo to Enhance Musculoskeletal Care
02:12pm, Wednesday, 07'th Aug 2024
Smith & Nephew (SNN) announces a collaboration with HOPCo to focus on enhancing solutions for ASC customers, physicians, and patients through the latter's digital health and analytics platforms.
Smith & Nephew jumps on progress with turnaround of hip and knee arm
03:58am, Thursday, 01'st Aug 2024
Shares in Smith & Nephew PLC (LSE:SN) sprang 7.7% higher as the replacement hip and knee specialist reported some encouraging elements in its interim results. Overall, the numbers for the first half
Smith & Nephew shares rise as profit beats market forecast
03:28am, Thursday, 01'st Aug 2024
Smith & Nephew's shares rose 9% on Thursday after the British medical equipment maker's half-year profit beat market forecast, helped by a strong performance in its orthopaedics segment.
Should Value Investors Buy Smith & Nephew SNATS (SNN) Stock?
10:46am, Wednesday, 24'th Jul 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Smith & Nephew's (SNN) CATALYSTEM System Gets FDA Clearance
01:30pm, Wednesday, 17'th Jul 2024
Smith & Nephew (SNN) announces the receipt of FDA clearance for its new CATALYSTEM Primary Hip System, which is intended to address the demands of primary hip surgery.
Activist Cevian has a stake in medical device company Smith & Nephew. How it may help improve margins
09:20am, Saturday, 13'th Jul 2024
British company Smith & Nephew is already a global leader in medical tech. Cevian could help it boost its profitability.
Smith & Nephew's (SNN) 5% Stake Acquired by Cevian Capital
12:20pm, Monday, 08'th Jul 2024
Smith & Nephew (SNN) eyes future growth as Cevian Capital purchases a 5% stake in the company.
